P. N., Smith S. M., Server A. C., Finkbeiner S., Stevens C. F., Jahr C.
and Weber E. (1989) Synthesis and characterization of a series of
diarylguanidines that are noncompetitive N-methyl-D-aspartate recep- 27.
tor antagonists with neuroprotective properties. Proc. Natl. Acad. Sci.
USA 86, 5631–5635. 28.
16. Kemp J. A., Foster A. C. and Wong E. H. F. (1987) Non-competitive
antagonists of excitatory amino acid receptors. Trends Neurosci. 10,
294 –298.
17. Lipton S. A. and Rosenberg P. A. (1994) Mechanisms of disease: 29.
Excitatory amino acids as a final common pathway for neurologic
disorders. New Engl. J. Med. 330, 613– 622.
18. Lodge D. and Johnson K. M. (1990) Noncompetitive excitatory amino
acid receptor antagonists. Trends Pharmacol. Sci. 11, 81– 86.
30.
19. McCulloch J. (1994) Glutamate receptor antagonists in cerebral ischaemia. J. Neural Transm. 43(suppl), 71–79.
20. McCulloch J., Bullock R. and Teasdale G. M. (1991) Excitatory amino
acid antagonists: Opportunities for the treatment of ischaemic brain
31.
damage in man. In: Excitatory Amino Acid Antagonists (Edited by
Meldrum B. S.), pp. 287–325. Blackwell, Oxford, UK.
21. McCulloch J., Owens J., Patterson J., Brown D. R. P., Teasdale G. M.
and Wyper D. J. (1994) Imaging NMDA receptor activation in cerebral
ischaemia in man with 123I-MK-801 and SPECT. In: Pharmacology of
Cerebral Ischaemia (Edited by Krieglstein J. and Oberpichler-Schwenk
32.
H.), pp. 233–238. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany.
33.
22. McCulloch J., Wallace M. C., Laurie D., Angerson W. J., Burns H. D.
and Gibson R. E. (1992) Imaging activation in the NMDA receptor
complex with 125Iodo-MK-801. In: Pharmacology of Cerebral Ischaemia
(Edited by Krieglstein J. and Oberpichler-Schwenk H.), pp. 59 – 63.
Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany. 34.
23. Meldrum B. and Garthwaite J. (1990) Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11, 379 –387.
24. Moerlein S. M. (1985) Regiospecific incorporation of no-carrier-added 35.
radiobromine and radioiodine into aromatic rings via halodegermylation. J. Chem. Soc. [Perkin 1] 1687–1692.
25. Moerlein S. M., Beyer W. and Stocklin G. (1988) No-carrier-added 36.
radiobromination and radioiodination of aromatic rings using in situ
generated peracetic-acid. J. Chem. Soc. [Perkin 1] 779 –786.
Moerlein S. M. and Coenen H. H. (1985) Regiospecific no-carrier-
